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SYNTHETIC HYPNOTICS IN THE BARBITURIC 
ACID SERIES 
ARTHUR W. DOX 
The increasing demand for sleep-producing drugs is perhaps one 
of the characteristics of the restless age in which we now live. Not 
a year passes but half a dozen new synthetic hypnotics appear in 
the patent literature and a few of these find their way into the 
drug market. Most of these fail to meet the claims made by the 
manufacturers and are soon discarded, and the physicians continue 
to prescribe the eight or ten more or less familiar drugs that have 
survived several decades of clinical experience. Meanwhile, the 
chemical and pharmaceutical laboratories continue their search 
for the ideal hypnotic, for it must be admitted that none of the 
hypnotics in present clay use are entirely free from certain ob-
jectionable qualities. 
Long before our era of chemical and pharmaceutical research 
the sleep-producing properties of opium and alcohol were widely 
known. In oriental countries hashish, or Cannabis indica, has been 
used for centuries, but this has never become popular in our west-
ern civilization. Among the natural drugs, hyocyamus is perhaps 
the only other hypnotic of any importance. The first three, opium, 
alcohol and cannabis, are decidedly habit-forming. As a matter 
of fact, only a very small percentage of the total consumption of 
these drugs can be considered legitimate in the sense of being 
used under circumstances where a physician would feel justified 
in prescribing them. 
Opium, including its chief constituent, morphine and the mor-
phine derivatives codeine, heroine, etc., has been both a blessing 
and a curse to humanity. For the relief of acute pain, especially 
in post-operative surgery, no satisfactory substitute has yet been 
discovered. On the other hand, the morphine habit has fastened 
itself upon thousands of otherwise useful citizens and left them 
physical and moral wrecks. The discovery of synthetic hypnotics 
which are now used in a great many cases where morphine was 
formerly prescribed represents, therefore, a distinct advance in 
medical science. It may be said in general that for the relief of 
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insomnia or sleeplessness due to other causes than acute pain, the 
use of morphine or its derivatives is no longer necessary. 
Curiously enough, none of the synthetic hypnotics bear the 
slightest chemical resemblance to morphine. The exact structure 
of the morphine molecule is still unknown, but we know that it 
is far more complex than any synthetic hypnotic thus far used. 
The presence of a phenanthrene nucleus, an oxygen bridge form-
ing a furane ring, two hydroxyls one of which is phenolic and th<:: 
other alcoholic, ancl a nitrogen ring bearing a methyl group, is 
about all that has been definitely proved of the morphine struc-
ture. On the other ha1id, some of our common sleep-producing 
drugs are extremely simple and easily synthesized. The difference 
is not so much in the size as in the compactness of the molecule. 
For example, morphine has a molecular weight of 285, and lumi-
nal, one of the most poweriul of our ~ynthetic hypnotics, a mole-
cular weight of 232; yet morphine contains five cyclic nuclei ancl 
luminal only two. 
The great advantage of the synthetic hypnotics over morphi'ne 
is in their lack of injurious effect upon the higber brain centers 
and in the fact that they are not habit-forming in the ordinary 
sense. Individuals are occasionally met with who rely to an 
unnecessary extent upon these drugs, but the habit, if it can be 
called such, is hardly a physiological craving. For that matter, 
any drug may be considered habit-forming. Self-medication is 
one of our favorite pastimes. \Ve have only to call to mind the 
number of people among our own acquaintance who resort to a 
dose of aspirin upon every possible pretext. \Vith the exception 
perhaps of chloral hydrate the ordinary sleep-producing drugs 
only rarely develop an injurious habit. The reason probably is 
their lack of eff~ct upon the higher brain centers and their failure 
to produce sensations of exhilaration or mental exaltation. 
In briefly reviewing the history of synthetic hypnotics, we find 
that chloral hydrate, CC/a CH(OH)2, was the first to be introduc-
ed into medicine. Like many others, this substance was known 
to chemists years before its medicinal properties were discovered. 
Liebig prepared and described chloral hydrate in 1832 but it was 
not until 1869 that Liebreich found it to be a hypnotic and in 
1874 it was introduced into the British Pharmacopoeia. The 
search for other hypnotics then began. Only those which may be 
regarded as distinct types and \vhich have come into extensive 
use will be alluded to in this brief discussion. Paraldehycle ( CH3 
CJT0) 3 made its appearance in 1883; urethane (C2H 50CONH2 ), 
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111 1885 ; hypnone ( C 6 H/.,,~O CH 3 ), in 1886; amylene hydrate 
((CH3 ) 2 C2 H 0 COH), in 1887; sulfonal ((CH3 ) 2 C(S0 2 C2II0 ) 2 ), 
in 1888; chloretone (CC/3 (CH3 ) 2COH), in 1899; and veronal 
((C2H;J 2 C(CONH) 2 CO), in 1903. 
Analogs and homologs of these in which, for example, bro-
mine is substituted for chlorine, or ethyl for methyl, and con-
densation products with other substances, have made their appear-
ance in great numbers. l\Iany are patented and sold under fan-
tastic names. In practically all cases their therapeutic action is 
clue to a chemical structure represented. by one or more of the 
substances listed above. 
As already stated, the ideal hypnotic has not yet been found. 
Chloral hydrate is regarded by many physicians as habit-forming, 
and it has a decidedly depressant action on the heart. Urethane, 
hypnone and paraldehyde are effective only in comparatively large 
doses and have a disagreeable nauseating taste. Paraldehyde is 
widely used in hospitals, but is so unpleasant to take that few 
physicians would risk losing their practice by administering it to 
private patients. Sulfonal, as well as its homolog, trional, has 
a tendency to destroy the blood corpuscles. Chloretone and ver-
onal are perhaps the most satisfactory, yet in <loses sufficient to 
produce quick results their action is too prolonged. The ideal hyp-
notic should have a high "factor of safety," that is, a wide range 
between effective close and toxic close, and thus minimize the 
clanger of over dosage. It should be prompt in its action and 
free from after effects. It should not interfere with circulation 
or respiration. And lastly, it should be non-habit forming and 
at the same time free from disagreeable taste or odor. 
Now what is the mode of action of these drugs? Many the-
ories have been proposed but not one of them is entirely satisfac-
tory. As has been stated, they are unlike morphine in that they 
do not affect the higher brain centers, their action being probably 
limited to the central nervous system and the medulla. The most 
ingenious explanation is known as the Overton-Meyer theory of 
narcosis. According to this theory the action of synthetic hypno-
tics is mechanical rather than chemical. Overton found that the 
effectiveness of these drugs is proportional to their "distribution 
coefficient," that is, the ratio of their solubility in fats and lipoids 
to their soTubility in water. Nerve tissue is composed largely of 
fats and lipoids, hence there would tend to be an accumulation in 
the nerve tissue of such drugs as are more soluble in lipoids than 
in water. The nervous system thus becomes partly saturated with 
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a foreign substance and its functioning is mechanically retarded. 
In support of this theory we have the fact that animals in an 
emaciated condition, in other words, with less adipose tissue to 
absorb the drug, are more susceptible to hypnotics, also the fact 
that certain hypnotics, for example veronal, undergo practically 
no change in the body and are finally excreted unchanged. On the 
other hand, many substances in the aromatic series for which 
hypnotic properties might be predicted from their distribution 
coefficients, have no such action. Possibly, as Traube suggests, 
surface tension may also be an important factor. Fuchs has 
pointed out that all of 0the hypnotics with the exception of the 
sulfones contain a hydroxyl group, or a carbonyl group capable 
of tautomerizing to a hydroxyl. The sulfones are the most readily 
destroyed in the body and their apparent exception may be ruled 
out on the assumption that a transition product containing a hy-
droxyl is formed from them. It must be admitted, nevertheless, 
that the action of hypnotic drugs is still as much a mystery as the 
phenomenon of natural sleep. 
A discussion of the various types of hypnotics and their chief 
representatives would be far beyond the scope of this paper. \Ve 
shall limit ourselves therefore to the newest type, the veronal 
series, in which the writer has been conducting investigations dur-
ing the past three years. 
Veronal, also known as Barbital, was introduced into medicine 
by Fischer and Mering in 1903. It is 5, 5-diethylbarbituric acid, 
(C2H 5 ) 2C(CONH) 2CO. This substance, like chloral hydrate, 
was known to chemists long before its physiological action was 
discovered. It was first prepared by Conrad and Guthzeit in 1882 
by the action of ethyl iodide on the silver salt of barbituric acid. 
For twenty years no further attention was paid to it. Then came 
the announcement by Fischer and Mering of the remarkable sleep-
producing properties of this substance, and a description by Fisch-
er and Dilthey of a far more satisfactory and economical method 
of preparing it. Various processes for the manufacture of veron-
al have been patented, but the method originally described by 
Fischer and Dilthey-the condensation of ethyl diethylmalonate 
with urea in the presence of sodium ethylate- is the only one that 
has been successful on a commercial scale. 
Like all of Emil Fischer's work this investigation ·was pains-
taking and thorough. He prepared a number of homologs of 
veronal, among which may be mentioned dimethyl, methyJethyJ, 
methylpropyl, dipropyl, ethylpropyl, diisobutyl, diisoamyl and di-
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benzyl-barbitnric acids. \Vith increasing size of these alkyl groups 
the hypnotic effect increases up to a certain point, then decreases. 
As might be expected, the two extremes, dimethyl and cliisoarnyl, 
have very little action, and the intermediate derivatives follow a 
parabolic curve with cliprupyl at the peak. Diethylbarbituric acid 
with further substitution of the nitrogen, as for example, S,.5-die-
thyl-1-methylbarbitmic '.Vi,; was found to he toxic. Rephcerncnt 
Qf the oxygen in the 2-puition by sulphur, as in 5,S-diethyl-2-
thiobarbituric acid gave a toxic product, whereas a similar re-
placement by the irnino group, NH, as in diethylmalonylguanidine, 
gave an inert substance. All of these pr.oclucts, it will be noted, 
carry two alkyl groups on the 5-carbon atom of the pyrimidine 
nucleus. If only one alkyl is present as in monoethyl or mono-
propyl-barbituric acid hypnotic action is absent. This is also the 
case when the barbituric acid ring is opened up, as for example, 
the ureide of <liethylmalonic acid. 
The dialkylbarbituric acids \Yhich had been almost entirely neg-
lected during the twenty years preceding Fischer's· patent now 
became the subject of feverish research activity particularly in the 
German laboratories. Patent after patent appeared in rapid suc-
cession, mainly of processes for the manufacture of veronal. Most 
of these processes are roundabout methods of synthesis and could 
not possibly compete with Fischer's method on a commercial scale. 
Among the other clialkylbarbituric acids of therapeutic value 
for which specific patents have been granted m;cy be mentioned 
phenylethyl, cyclohexylethyl, diallyl, phenylallyl, clibutyl and iso-
propylethyl-harbitnric acids. Phenylethylbarbituric acid, sold 
under the names "luminal" and "phenobarbital" is by far the most 
important of these. It is said to be two and one-half times as pow-
erful as veronal, and is used extensively in the treatment of epilep-
sy. \Vhereas the hypnotic effect of veronal is sometimes preceded 
by a brief period of excitement, luminal manifests its sedative ac-
tion almost immediately, and for that reason is often used in the 
treatment of violent cases of insanity and to ward off epileptic seiz-
ures. Of the other derivatives just mentioned, the diallyl is about 
the only one vvhich can be obtained in the market. It is sold under 
the name "dial." It is undoubtedly a good hypnotic, but the 
Council of Pharmacy and Chemistry of the 1\merican l\Iedical 
Association has refused to accept it for "New and Non-Official 
Remedies" because of an overstatement of the manufacturer's 
claims. The most recent derivative is perhaps isopropylallylbar-
bituric acid, known as "allonal." At the present writing, one of 
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our large pharmaceutical houses is about to put isoamylethylbar-
bituric acid on the market. A discussion of these new derivative~ 
is out of the question because very few data are available except 
the advertising propaganda. As regards cost of manufacture, 
none of these derivatives can compete with veronal, especially 
those containing two different alkyl groups. Superior merits or 
special uses must be demonstrated if the product is to be a commer-
cial success. This was actually clone in the case of luminal, which 
however, is not a competitor of veronal, but a distinct drug used 
for special purposes. Butylethylbarbituric acid is on the European 
market made under the name "someryl." It was prepared and 
described by the writer several \veeks before Carnot and Tiffeneau 
published their description of it. Since the cost of manufacture 
by any conceivable process would be greater than that of veronal 
and its action is not essentially different, we did not consider it 
worth while to apply for a patent. 
The study of many other drugs has shown that the physiological 
action is often clue to some particular grouping of atoms in the 
molecule. A classic example is the synthesis of the local anesthetic 
procaine based upon a study of the chemical structure of the al-
kaloid cocaine. Here it was found that the essential groupings 
are the benzoyl radical and a tertiary amine. A much simpler de-
rivative containing these two groupings was then prepared and 
found to be an excellent substitute for cocaine without the habit 
forming tendencies. Similarly, the ideal hypnotic may eventually 
be synthesized when we understand fully the structure of the mor-
phine molecule. For the present. however, we are interested in 
determining the essential grouping to which veronal owes its hyp-
notic action. First of all, what grouping has it in common with 
other known hypnotics? Phenylethyl-hydantoin, diethylbromace-
tylurea, diethylhomophthalimide and phenylethyldiketotetrahydro-
oxazole have, in common with veronal, the grouping CR2-CO-.l'·v' H-
CO-. It is not unlikely that this grouping is a "hypnophore," to 
coin a word analogous to the familiar "chromophore" of the dye 
chemist. The alkyl groups ( R,) may of course be varied within 
a limited range. 
One of the alkyls may be a cyclic structure, e. g. phenyl or 
cyclohexyl, but thns far the other alkyl has invariably been an 
open chain. Now how would the physiological properties of these 
dialkylbarbituric acids be affected if the two alkyls were linked 
together into a cyclic structure? The molecule would then con-
sist of hvo cyclic nuclei with a single carbon atom common to 
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both; in other words, a spiro deri1.:afrvc, a type of compounds of 
which comparatively few representatives are known. The writer, 
in collaboration with Lester Yoder, succeeded in preparing several 
such compounds. The spiro derivative trimethylenebarbituric acid 
corresponds to methylethylbarbituric acid in which the methyl and 
ethyl groups are closed into a four-membered ring. Similarly, 
pentamethylenebarbituric acid corresponds to ethylpropylbarbi-
turic acid with the terminal carbons of the ethyl and propyl groups 
united into a six-membered ring. To our amazement, both of 
these derivatives were entirely devoid of hypnotic action. Like-
wise, the alkylidene-barbituric acids, with a single alkyl group 
linked to the 5-carbon of the pyrimidine ring through a double 
bond, as benzylidene-barbituric acid, CH,CH=C(CONH),CO, 
are inactive. 
\Ve then undertook to vary the urea grouping of the barbituric 
acid derivatives. By condensing dialkylmalonic esters with amid-
ines instead of urea we obtained a very interesting series of py-
rimidines in which the -NH-CO-KH- grouping of the veronal 
series was replaced by -KH-CR = N-. These were devoid of 
hypnotic action. Evidently then the "hypnophore" group referred 
to above is actually the essential part of the molecule. Even so 
slight an alteration of the urea grouping as the reduction of the 
carbonyl to a methylene had been found by Einhorn to destroy the 
hypnotic properties of veronal. 
Another series of dialkylbarbituric acids which we prepared 
represents the veronal series with a benzyl group in place of one 
of the ethyls. Since the comparatively recent introduction of 
benzyl derivatives into medicine as antispasmodics, it occurred to 
us that the substitution of a benzyl for an ethyl in veronal might 
give us a derivative with both hypnotic and antispasmodic proper-
ties. Benzylethylbarbituric acid and a number of its homologs 
were accordingly prepared. The most active member of the ser-
ies was the benzylethyl derivative itself. As we anticipated, it 
was a powerful hypnotic, but contrary to our expectations, in-
stead of being an antispasmodic it was quite the reverse. The 
narcosis produced in the experimental animals was preceded by 
tetanic convulsions. Since the publication of this work our results 
have been confirmed by Shonle and Moment of Indianapolis. 
These startling results led us to a more critical examination of 
Macht's deductions regarding benzyl therapy. We are now con-
vinced that the supposed "specific benzyl effect" claimed by Macht 
is simply a higher alcohol effect. \Vith the benzyl attached di-
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rectly to carbon as in our derivative a hydrolysis into benzyl al-
cohol is extremely unlikely, whereas in benzyl benzoate and other 
benzyl esters such hydrolysis readily occurs. On the basis of 
chemical structure our derivative, with the benzyl attached direct-
ly to the carbon of a cyclic nucleus, resembles the alkaloid papa-
verine, on which Macht based his deductions, more closely than 
do his benzyl esters. At present we see no possibility of utilizing 
benzy lethy lbarbi turic acid therapeutically. 
Of the various preparations on the market containing dialkyl-
barbituric acids only those representing salts with bases can be 
considered chemical compounds. The sodium salt of veronal, for 
example, appears under the name "medinal." It has the advantage 
of greater solubility and for that reason can be used hypodermical-
ly, but its action is no different from that of veronal. Salts with 
alkaloids can also be procured, and in these preparations the ver-
onal and the alkaloid exert their specific actions independently. 
Other preparations, despite the manufacturer's claims to the con-
trary, are mere mixtures and not chemical combinations. We 
considered it of interest therefore to determine the effect of com-
bining a dialkylbarbituric acid in a stable union with other sub-
stances of known physiological activity. The products represent 
ethylpropyl- and isoamylpropyl-barbituric acids united through the 
gamma carbon of the propyl group to diethylamine, ethylaniline, 
acetanilide and phenacetin, respectively. Acetanilide and phena-
cetin, for example, are antipyretics and ethylpropylbarbituric acid 
a strong hypnotic. Preliminary tests showed that mixtures in 
molecular proportions retained at least 'the hypnotic action of the 
barbituric acid. It remained to be determined what the effect 
would be of uniting the two constituents in a stable union. The 
synthesis of a typical preparation involved the following steps:-
Ethyl malonate, ethyl ethylmalonate, ethyl ethylbromopropyl-ma-
lonate, ethyl ethylacetphenetidinopropyl-malonate, ethylacetphene-
tidino-propylbarbituric acid. The final product may be represented 
by the formula, C2Hr.O.CcH4N (COCH3 )CH2 CH2CH2(C2H 5 )-
C(CONH)2CO. The substance proved to be so stable that even 
the acetyl group was very difficult to remove by boiling with strong 
acid or alkali. Animal tests showed that the hypnotic properties 
0f the barbituric acid had disappeared entirely. This we attribute 
to the insolubility of the substance which prevents absorption and 
to its great stability which interferes with the liberation of a simple 
dialkylbarbituric acid by hydrolysis. On the other hand, the cor-
responding derivative with diethylamine in place of phenacetin 
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was soluble in water but less soluble in organic solvents, thus re-
versing the distribution coefficient required by the Overton-Meyer 
theory. \Ve believe that in these derivatives a molecular magni-
tude has been reached considerably beyond that encountered in 
the ordinary synthetic hypnotics or in morphine itself, without, 
however, acquiring the compactness of the alkaloid molecule. 
It will be noted from the foregoing discussion that luminal 
(phenyletl~ylbarbituric acid) is the only simple disubstituted bar-
bituric acid containing an aromatic radical linked directly to the 
pyrimidine nucleus. \Ve found that ethylphenoxybarbituric acid, 
vYhich is luminal with an oxygen inserted between the phenyl 
group and the pyrimidine ring, was not a hypnotic. Evidently 
the phenyl must be attached directly to carbon. The question 
now arises whether the introduction of a second phenyl would 
increase the physiological activity stilI further. A search through 
the literature showed that no attempts have been recorded to pre-
pare such derivatives. The simplest of this type would be 5.5-di-
phenyl-barbituric acid, i. e., veronal with both ethyls replaced by 
phenyls. An isomer of this has been described, viz., 1, 3-diphenyl-
barbituric acid, but here both of the phenyls are attached to ni-
trogen instead of carbon and the substance therefore does not be-
long to the veronal series. Our attempts to prepare 5, 5-diphenyl-
barbituric acid were unsuccessful owing to the instability of ethyl 
diphenylmalonate which was used in the final step of the synthesis. 
\Ve did however, prepare a substituted derivative, namely, di-
(p-hydroxyphenyl )-barbituric acid, (HOC6 H 4 ) 2C( CONH) 2CO, 
also its isomer diphenoxybarbituric acid, ( CH,Q) ,c (CON I!) ,co. 
Neither of these substances showed physiological activity. 
An examination of the structure of the synthetic hypnotics 
commonly used shows that practicaliy all are aliphatic derivatives. 
\Vhere an aromatic grouping is present, as in luminal and phenyl-
ethylhydantoin, the aromatic group comprises a relatively small 
part of the molecule. On the other hand, aromatic deriYatives 
for which hypnotic properties might be predicted on the basis of 
their distribution coefficient arnl molecular stability are generally 
inert. 
H ypnone ( acetophenone) perhaps comes the nearest to being 
an aromatic hypnotic, but a further increase in the aromatic group-
ings, as in benzophenone :i.nd benzhydrol, causes the hypnotic ac-
tion to disappear. It is of interest to note that the two barbituric 
acids under discussion consist essentially of two benzene rings and 
one pyrimidine ring, that is, they are preponderantly aromatic. 
9
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The hydantoins furnish a parallel case; phenylethylhydantoin, 
mainly aliphatic, is a hypnotic, while diphenylhydantoin, mainly 
aromatic, is not. Fnrther evidence is, of course, required to estab-
lish this point, but from the data at hand it would appear that a 
search for hypnotics among derivatives that are essentially aro-
matic is not very promising. 
Experimental hypnotics must, of course .. be thoronghly tested 
out with animals before even preliminary tests are made with hu-
man subjects. Various animals have been used for this purpose. 
Fischer and ::\T ering's original experiments with veronal and its 
homologs were performed with dogs. The more active hypnotics 
when administered orally in a one gram dose to a dog of a\'erage 
weight cause first a marked muscular incoordination followed by 
drowsiness and finally sleep which lasts six or eight hours. \Ve 
fournl in our experiments that preliminary tests conld be per-
formed very satisfactorily with white mice by intraperitoneal in-
jections of either an ac1neons solution of the sodium salt or an 
olive oil solution of the free acid. The advantages of this method 
are the smaller amount of material re(1uired for the test, a great 
saving of laboratory space and the avoidance of certain disagree-
able features always met with in experimentation with larger 
animals. For example the effective dose of veronal fc;r a twenty 
gram mouse is only 0.006 g. \Vithin twenty minutes the mouse 
is in a state of coma which lasts for several hours, after which 
recovery takes place without any apparent after-effects. This 
method we have found very useful as a preliminary test to elimi-
nate from further consideration derivatives which are physiologi-
cally inert. 
From our study thus far of the barbituric acids certain nega-
tive data are presented for the purpose of narrowing clown the 
scope of future investigation. The following tentative conclu-
sions may be drawn, supplementary to those of Fischer and Mer-
ing. 
1. To manifest hypnotic action without undesirable after-ef-
fects, the two alkyl groups in the 5-position of the pyrimidine 
ring should have a total number of carbon atoms not less than 
four or more than eight. 
2. At least one of the alkyl groups must be in the form of an 
open chain. 
3. The benzyl group is undesirable because of its tendency to 
cause convulsions. 
10
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4. The urea grouping -NH-CO-NH- may not be replaced by 
the amidine grnupiug -NH-CR=.:\-. 
5. Increase in the size of the molernle heyoncl, say, a molecu-
lar weight of 250 results in loss of hypnotic activity. 
6. · Not more than one of the two alkyl groups should be aro-
matic in character. 
7. \Ve believe that the hypnophore group in the veronal series 
is -CR,-CO-N H-CO-. 
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U. S. PATENTS ON DTALKYLBARBITURIC ACIDS 
Diethyl 
Phenylmethyl 
Phcnylethyl 
Diallyl 
Phenvlallvl 
I sopropylethyl 
Dibutyl 
Isopropylallyl 
782,739 
1,025,526 
1,025,872 
1,042,265 
1,056,793 
1.331,712 
1,255,951 
1,444,802 
PARKE, D,\vrs AND Co'.ltPANY, 
Di<:TROIT, MICHIGAN. 
(1905) 
(1912) 
(1912) 
(1912) 
(1913) 
(1918) 
(1920) 
(1923) 
veronal 
l mn in al 
dial 
allonal 
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